{"title":"芒果植物化学富集锌-两性霉素B纳米偶联物:增强亲水性,降低毒性和ph敏感释放靶向抗念珠菌治疗","authors":"Divya Mathew , Benny Thomas , N.M. Sudheep , Surya Nair , E.K. Radhakrishnan","doi":"10.1016/j.apt.2025.104895","DOIUrl":null,"url":null,"abstract":"<div><div>Amphotericin B (AmB) faces limitations in antifungal applications due to toxicity and poor solubility. This study developed AmB conjugate with green-synthesized zinc oxide nanoparticles (gZnONPs) using <em>Mangifera indica</em> leaf extract (MLE) to enhance pH sensitivity and hydrophilicity. FTIR analysis confirmed AmB conjugation and MLE phytocore on the surface of the gZnONPs, while UV–Vis spectroscopy showed a red shift from 362 to 394 nm after AmB conjugation, indicating successful binding. The conjugate showed increased solubility from 0.31 to 125 µg/mL and enhanced hydrophilicity (contact angle reduced from 53° to 34°). The enhanced saturation solubility might be due to NP size effects, reduced crystallinity, phytochemical-induced hydrophilicity, and effective drug encapsulation, collectively improving the bioavailability and therapeutic efficacy of AmB at the target site. The AmB release profile showed pH-sensitive, sustained release, with higher rates at infection-site (pH 5.5), ensuring prolonged therapeutic effects. Antifungal tests demonstrated significant zone of inhibition for the conjugate (47 mm) against <em>Candida albicans</em>, outperforming MLE (34 mm), AmB (41 mm) and ZnONPs (37 mm) alone. The conjugate showed 2.4-fold higher LC<sub>50</sub> (446.51 μg/mL) over AmB (186.39 μg/mL), suggesting reduced toxicity, likely due to phytochemical capping minimizing non-specific interactions with healthy cells and pH-sensitive, targeted release. Further, the hemolysis study demonstrated that ZnONPs significantly reduced AmB-induced RBC lysis (4.1 % at 24 h vs. 18.1 % for pure AmB), outperforming lipid-based formulations (9–14 %), highlighting their potential as a safer nanocarrier for AmB delivery while mitigating dose-dependent hemolysis. These findings highlight the potential of gZnONPs as an effective nanocarrier for AmB, offering enhanced solubility, targeted antifungal activity, and reduced toxicity, making it a promising alternative to conventional formulations.</div></div>","PeriodicalId":7232,"journal":{"name":"Advanced Powder Technology","volume":"36 6","pages":"Article 104895"},"PeriodicalIF":4.2000,"publicationDate":"2025-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Mangifera indica phytochemical enriched ZnO-Amphotericin B Nanoconjugates: Enhanced hydrophilicity, reduced toxicity and pH-sensitive release for targeted anti-Candida therapy\",\"authors\":\"Divya Mathew , Benny Thomas , N.M. Sudheep , Surya Nair , E.K. Radhakrishnan\",\"doi\":\"10.1016/j.apt.2025.104895\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>Amphotericin B (AmB) faces limitations in antifungal applications due to toxicity and poor solubility. This study developed AmB conjugate with green-synthesized zinc oxide nanoparticles (gZnONPs) using <em>Mangifera indica</em> leaf extract (MLE) to enhance pH sensitivity and hydrophilicity. FTIR analysis confirmed AmB conjugation and MLE phytocore on the surface of the gZnONPs, while UV–Vis spectroscopy showed a red shift from 362 to 394 nm after AmB conjugation, indicating successful binding. The conjugate showed increased solubility from 0.31 to 125 µg/mL and enhanced hydrophilicity (contact angle reduced from 53° to 34°). The enhanced saturation solubility might be due to NP size effects, reduced crystallinity, phytochemical-induced hydrophilicity, and effective drug encapsulation, collectively improving the bioavailability and therapeutic efficacy of AmB at the target site. The AmB release profile showed pH-sensitive, sustained release, with higher rates at infection-site (pH 5.5), ensuring prolonged therapeutic effects. Antifungal tests demonstrated significant zone of inhibition for the conjugate (47 mm) against <em>Candida albicans</em>, outperforming MLE (34 mm), AmB (41 mm) and ZnONPs (37 mm) alone. The conjugate showed 2.4-fold higher LC<sub>50</sub> (446.51 μg/mL) over AmB (186.39 μg/mL), suggesting reduced toxicity, likely due to phytochemical capping minimizing non-specific interactions with healthy cells and pH-sensitive, targeted release. Further, the hemolysis study demonstrated that ZnONPs significantly reduced AmB-induced RBC lysis (4.1 % at 24 h vs. 18.1 % for pure AmB), outperforming lipid-based formulations (9–14 %), highlighting their potential as a safer nanocarrier for AmB delivery while mitigating dose-dependent hemolysis. These findings highlight the potential of gZnONPs as an effective nanocarrier for AmB, offering enhanced solubility, targeted antifungal activity, and reduced toxicity, making it a promising alternative to conventional formulations.</div></div>\",\"PeriodicalId\":7232,\"journal\":{\"name\":\"Advanced Powder Technology\",\"volume\":\"36 6\",\"pages\":\"Article 104895\"},\"PeriodicalIF\":4.2000,\"publicationDate\":\"2025-04-25\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advanced Powder Technology\",\"FirstCategoryId\":\"5\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0921883125001165\",\"RegionNum\":2,\"RegionCategory\":\"工程技术\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q2\",\"JCRName\":\"ENGINEERING, CHEMICAL\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advanced Powder Technology","FirstCategoryId":"5","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0921883125001165","RegionNum":2,"RegionCategory":"工程技术","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"ENGINEERING, CHEMICAL","Score":null,"Total":0}
Mangifera indica phytochemical enriched ZnO-Amphotericin B Nanoconjugates: Enhanced hydrophilicity, reduced toxicity and pH-sensitive release for targeted anti-Candida therapy
Amphotericin B (AmB) faces limitations in antifungal applications due to toxicity and poor solubility. This study developed AmB conjugate with green-synthesized zinc oxide nanoparticles (gZnONPs) using Mangifera indica leaf extract (MLE) to enhance pH sensitivity and hydrophilicity. FTIR analysis confirmed AmB conjugation and MLE phytocore on the surface of the gZnONPs, while UV–Vis spectroscopy showed a red shift from 362 to 394 nm after AmB conjugation, indicating successful binding. The conjugate showed increased solubility from 0.31 to 125 µg/mL and enhanced hydrophilicity (contact angle reduced from 53° to 34°). The enhanced saturation solubility might be due to NP size effects, reduced crystallinity, phytochemical-induced hydrophilicity, and effective drug encapsulation, collectively improving the bioavailability and therapeutic efficacy of AmB at the target site. The AmB release profile showed pH-sensitive, sustained release, with higher rates at infection-site (pH 5.5), ensuring prolonged therapeutic effects. Antifungal tests demonstrated significant zone of inhibition for the conjugate (47 mm) against Candida albicans, outperforming MLE (34 mm), AmB (41 mm) and ZnONPs (37 mm) alone. The conjugate showed 2.4-fold higher LC50 (446.51 μg/mL) over AmB (186.39 μg/mL), suggesting reduced toxicity, likely due to phytochemical capping minimizing non-specific interactions with healthy cells and pH-sensitive, targeted release. Further, the hemolysis study demonstrated that ZnONPs significantly reduced AmB-induced RBC lysis (4.1 % at 24 h vs. 18.1 % for pure AmB), outperforming lipid-based formulations (9–14 %), highlighting their potential as a safer nanocarrier for AmB delivery while mitigating dose-dependent hemolysis. These findings highlight the potential of gZnONPs as an effective nanocarrier for AmB, offering enhanced solubility, targeted antifungal activity, and reduced toxicity, making it a promising alternative to conventional formulations.
期刊介绍:
The aim of Advanced Powder Technology is to meet the demand for an international journal that integrates all aspects of science and technology research on powder and particulate materials. The journal fulfills this purpose by publishing original research papers, rapid communications, reviews, and translated articles by prominent researchers worldwide.
The editorial work of Advanced Powder Technology, which was founded as the International Journal of the Society of Powder Technology, Japan, is now shared by distinguished board members, who operate in a unique framework designed to respond to the increasing global demand for articles on not only powder and particles, but also on various materials produced from them.
Advanced Powder Technology covers various areas, but a discussion of powder and particles is required in articles. Topics include: Production of powder and particulate materials in gases and liquids(nanoparticles, fine ceramics, pharmaceuticals, novel functional materials, etc.); Aerosol and colloidal processing; Powder and particle characterization; Dynamics and phenomena; Calculation and simulation (CFD, DEM, Monte Carlo method, population balance, etc.); Measurement and control of powder processes; Particle modification; Comminution; Powder handling and operations (storage, transport, granulation, separation, fluidization, etc.)